Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00090025
Status:
TERMINATED
Last Update Posted:
2009-01-14
First Post:
2004-08-19
Brief Title:
XL119 Versus 5-Fluorouracil 5-FU Plus Leucovorin LV in Subjects With Advanced Biliary Tumors
Sponsor:
Helsinn Healthcare SA
Organization:
Helsinn Healthcare SA
Organization Data
Organization:
Helsinn Healthcare SA
Class:
INDUSTRY
Study ID:
XL119-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Helsinn Healthcare SA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Helsinn Healthcare SA
Old Organization:
Pharma Company Sponsor